Get started
Work

Webinar as an Informational Resource on Trastuzumab Biosimilars: Planning, Promotion, Execution, and Evaluation

Year: 2022
Type: article
Abstract: Despite the incorporation of trastuzumab biosimilars (to treat HER2-positive breast cancer) in clinical practice guidelines, gaps remain such as patient and clinician education. We hosted a webinar comprised of a panel of biosimilars experts, oncologists, pharmacist, infusion nurse, and a patient advocate. The outcomes of the webinar include audience responses to pre- and post-webinar questionnaires, educational benefits, real-time opportunities to ask questions, and a recording. Education needs to be tailored to the needs of both, patients and clinicians.
DOI: 10.1080/07357907.2022.2093895
Authors: Elizabeth Lerner Papautsky, Martha Carlson, Sheila Marie Johnson, Hannah Montague, Leeann Valero, Deanna J. Attai, R. Donald Harvey, Gary H. Lyman, Maryam Lustberg
Institutions: University of Illinois Chicago, University of Illinois Hospital & Health Sciences System, University of California, Los Angeles, Emory University, Winship Cancer Institute, University of Washington, Fred Hutch Cancer Center, Yale University, Smilow Cancer Hospital
Language: English
Subfield: Immunology
Open Access status: hybrid
OpenAlex ID: W4283728012
FWCI: 0.096
Cites: 9
Cited by: 1
Related to: 10